Skip to main content
Top

Endocrine Pathology

Issue 2/2012

Content (8 Articles)

BRAF V600E Mutation in Papillary Thyroid Carcinoma: Significant Association with Node Metastases and Extra Thyroidal Invasion

Avik Chakraborty, Archana Narkar, Rita Mukhopadhyaya, Shubhada Kane, Anil D’Cruz, M. G. R. Rajan

Pathological Findings of Thyroid Nodules After Percutaneous Laser Ablation

Simonetta Piana, Fabrizio Riganti, Elisabetta Froio, Massimiliano Andrioli, Claudio M. Pacella, Roberto Valcavi

Different Clonal Origin of Bilateral Papillary Thyroid Carcinoma, with a Review of the Literature

Elisabetta Kuhn, Linda Teller, Simonetta Piana, Juan Rosai, Maria J. Merino

Tumefactive Postmenopausal Gonadotroph Cell Hyperplasia

Mark Jentoft, Bernd W. Scheithauer, Olga Moshkin, Eva Horvath, Phillip C. Collins, Luis V. Syro, Kalman Kovacs

Bilateral Adrenocortical Oncocytoma with Bilateral Myelolipomatous Metaplasia

Charu Shastri, Chanchal Rana, Niraj Kumari, Gaurav Agarwal, Narendra Krishnani

Expression and Clinical Significance of Wnt Players and Survivin in Pituitary Tumours

Robert Formosa, Mark Gruppetta, Sharon Falzon, Graziella Santillo, James DeGaetano, Angela Xuereb-Anastasi, Josanne Vassallo

Images in Endocrine Pathology: Spindle Cell Lesion of the Thyroid Gland

Esther Diana Rossi, Maurizio Martini, Nicola Cingolani, Renzo Ranaldi, Guido Fadda

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine